# Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

> **NCT03195673** · PHASE2 · UNKNOWN · sponsor: **Capital Medical University** · enrollment: 160 (estimated)

## Conditions studied

- Carotid Artery Stenosis

## Interventions

- **DRUG:** Terazosin
- **PROCEDURE:** Carotid artery stenting

## Key facts

- **NCT ID:** NCT03195673
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-02
- **Primary completion:** 2019-11-15
- **Final completion:** 2019-12-15
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2018-12-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03195673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03195673, "Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03195673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*